Document Detail

Recurrent severe alcoholic hepatitis: clinical characteristics and outcomes.
MedLine Citation:
PMID:  23628964     Owner:  NLM     Status:  MEDLINE    
BACKGROUND AND AIMS: Despite high recidivism rates in those treated for alcoholism, recurrent episodes of severe alcoholic hepatitis (SAH) have not been described. Our aim was to assess the clinical characteristics and outcomes in recurrent SAH.
PATIENTS AND METHODS: A retrospective review of patient records was carried out. Recurrent SAH was defined as two or more discrete episodes of SAH (discriminant function≥32) coinciding with recidivism in the same patient, with documented improvement/resolution of jaundice during intervening periods of abstinence.
RESULTS: Of 56 patients with recidivism following index presentation with SAH, 10 (17.9%) developed recurrent SAH. We report on 17 episodes in seven patients with complete data. The mean age and duration of alcohol use were 47.9±7.4 and 16.1±5.2 years, respectively. Compared with those without recurrence, the cohort with recurrent SAH were more likely to be women (57.1 vs. 34.8%, P=0.405), had higher alcohol consumption during relapse (16.0±15.3 vs. 11.3±8.1 U/day, P=0.591) and a recidivism pattern of alcohol relapse after initial abstinence rather than continuous alcohol use. Recurrent episodes were more severe compared with the index one (discriminant function 70.4±27.9 vs. 50.5±10.9; MELD score 26.2±3.7 vs. 22.1±1.5, P<0.05), the overall mortality being 57.1%. Treatment responses to corticosteroids were consistent in 66.7% of patients.
CONCLUSION: Approximately 18% of patients, especially women, develop recurrent SAH because of recidivism, with increasing disease severity and mortality approaching 60%. Our data underscore the urgent need to develop strategies to prevent recidivism following index presentation with SAH.
Jonathan R Potts; Mark R Howard; Sumita Verma
Related Documents :
3682434 - A transparent over-tube for endoscopic injection sclerotherapy and results in patients ...
8301064 - A prospective randomized study to evaluate propranolol in patients undergoing long-term...
20883424 - Effect of endoscopic injection therapy with combined cyanoacrylate and lipiodol for ble...
305764 - Survival following infusion of pitressin into the superior mesenteric artery to control...
10406604 - The treatment of traumatic optic neuropathy: the international optic nerve trauma study.
23053444 - Treatment of pilonidal disease by combination of pit excision and phenol application.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  European journal of gastroenterology & hepatology     Volume:  25     ISSN:  1473-5687     ISO Abbreviation:  Eur J Gastroenterol Hepatol     Publication Date:  2013 Jun 
Date Detail:
Created Date:  2013-04-30     Completed Date:  2013-11-22     Revised Date:  2014-02-07    
Medline Journal Info:
Nlm Unique ID:  9000874     Medline TA:  Eur J Gastroenterol Hepatol     Country:  England    
Other Details:
Languages:  eng     Pagination:  659-64     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Bilirubin / blood
Biological Markers / blood
Ethanol / administration & dosage
Glucocorticoids / therapeutic use
Hepatitis, Alcoholic / drug therapy,  etiology*,  pathology
Liver / pathology
Middle Aged
Retrospective Studies
Risk Factors
Sex Factors
Treatment Outcome
Reg. No./Substance:
0/Biological Markers; 0/Glucocorticoids; 3K9958V90M/Ethanol; RFM9X3LJ49/Bilirubin
Erratum In:
Eur J Gastroenterol Hepatol. 2014 Feb;26(2):253

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Multidisciplinary strategies to improve treatment outcomes in hepatocellular carcinoma: a European p...
Next Document:  Influence of adsorption thermodynamics on guest diffusivities in nanoporous crystalline materials.